Hanmi Pharm. Co., Ltd. (128940.KS)
KRW 269500.0
(-1.46%)
KRW 269500.0
(-1.46%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | 216.53 Billion | 162.26 Billion | 201.92 Billion | 151.53 Billion | 12.44 Billion | 25.98 Billion |
| Net Income | 146.23 Billion | 101.55 Billion | 81.47 Billion | 17.28 Billion | 63.86 Billion | 34.15 Billion |
| Depreciation & Amortization | 98.45 Billion | 96.84 Billion | 89.08 Billion | 61.33 Billion | 55.41 Billion | 47.19 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -57.39 Billion | -73.68 Billion | -53.51 Billion | 42.07 Billion | -136.95 Billion | -97.92 Billion |
| Other non-cash items | 29.24 Billion | 37.55 Billion | 84.87 Billion | 30.83 Billion | 30.12 Billion | 42.55 Billion |
| Investing Cash Flow | -183.47 Billion | -181.4 Billion | -43.38 Billion | -45.16 Billion | -172.94 Billion | -145.82 Billion |
| Investments in PPE | -47.74 Billion | -49.59 Billion | -34.42 Billion | -57.83 Billion | -178.37 Billion | -211.23 Billion |
| Acquisitions | 2.6 Billion | -25.77 Billion | -14.11 Billion | -15.85 Billion | -9.39 Billion | -606.5 Million |
| Investment purchases | -94.77 Billion | -92.92 Billion | -7.73 Billion | -2.53 Billion | -31.92 Billion | 28.96 Billion |
| Sales/Maturities of investments | 90.37 Billion | 86.58 Million | 785.9 Million | 16.53 Billion | 36.59 Billion | 64.9 Billion |
| Other Investing Activities | -133.93 Billion | -13.2 Billion | 12.1 Billion | 14.53 Billion | 10.15 Billion | -27.85 Billion |
| Financing Cash Flow | -126.78 Billion | -36.86 Billion | -113.33 Billion | -65.19 Billion | 198.59 Billion | 140.44 Billion |
| Debt repayment | -103.37 Billion | -260.97 Billion | -232.37 Billion | -232.28 Billion | -190.9 Billion | -268.8 Billion |
| Dividends payments | -17.99 Billion | -5.99 Billion | -5.88 Billion | -8.14 Billion | -5.66 Billion | -8.95 Billion |
| Common Stock Repurchased | -3.07 Billion | -3.83 Billion | -4.87 Billion | -3.08 Billion | -3.86 Billion | -5.58 Billion |
| Common Stock Issuance | 93.51 Million | - | - | - | 399.11 Billion | - |
| Other Financing Activities | -2.44 Billion | 233.93 Billion | 129.79 Billion | 178.31 Billion | -91.51 Million | 423.78 Billion |
| Accounts receivables | -2.6 Billion | 38.19 Billion | -74.31 Billion | 33.65 Billion | -10.51 Billion | 55.68 Billion |
| Accounts payables | 5.57 Billion | -2.73 Billion | 9.79 Billion | -5.3 Billion | -7.14 Billion | 3.33 Billion |
| Inventory | -16.9 Billion | -14.36 Billion | 18.91 Billion | 4.88 Billion | -74.09 Billion | -27.12 Billion |
| Other working capital | -43.46 Billion | -94.77 Billion | -7.91 Billion | 8.84 Billion | -45.19 Billion | -129.81 Billion |
| Cash at beginning of period | 147.32 Billion | 209.22 Billion | 146.15 Billion | 106.11 Billion | 67.33 Billion | 47.26 Billion |
| Cash at end of period | 54.98 Billion | 147.32 Billion | 209.22 Billion | 146.15 Billion | 106.11 Billion | 67.33 Billion |
| Capital Expenditure | -47.74 Billion | -49.59 Billion | -34.42 Billion | -57.83 Billion | -178.37 Billion | -211.23 Billion |
| Effect of forex changes on cash | 1.37 Billion | -5.89 Billion | 17.86 Billion | -1.13 Billion | 673.63 Million | -525.7 Million |
| Net cash flow / Change in cash | -92.34 Billion | -61.89 Billion | 63.06 Billion | 40.04 Billion | 38.77 Billion | 20.07 Billion |
| Free Cash Flow | 168.79 Billion | 112.67 Billion | 167.49 Billion | 93.69 Billion | -165.92 Billion | -185.24 Billion |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 Q4 | 2023 FY | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Operating Cash Flow | - | - | - | - | - | - |
| Net Income | 40.27 Billion | 55 Billion | 34.39 Billion | 146.23 Billion | 60.53 Billion | 18.74 Billion |
| Depreciation & Amortization | 24.34 Billion | 24.2 Billion | 24.61 Billion | 98.45 Billion | 24.49 Billion | 24.67 Billion |
| Deferred income taxes | - | - | - | - | - | - |
| Stock-based compensation | - | - | - | - | - | - |
| Change in working capital | -40.5 Billion | 41.25 Billion | -42.69 Billion | -57.39 Billion | -21.27 Billion | 3.81 Billion |
| Other non-cash items | 6.87 Billion | 6.04 Billion | 27.83 Billion | 29.24 Billion | -13.54 Billion | -2.52 Billion |
| Investing Cash Flow | -52.01 Billion | -48.15 Billion | -172.78 Billion | -183.47 Billion | -8.89 Billion | 40.82 Billion |
| Investments in PPE | -8.18 Billion | -15.9 Billion | -17.08 Billion | -47.74 Billion | -9.57 Billion | -11.49 Billion |
| Acquisitions | 6.4 Million | 35.4 Million | 635.91 Million | 2.6 Billion | -1.89 Billion | -1.1 Billion |
| Investment purchases | -14.26 Billion | -50.93 Billion | -90.73 Billion | -94.77 Billion | 70.7 Billion | -18.96 Billion |
| Sales/Maturities of investments | -18.6 Billion | 18.6 Billion | 90.37 Billion | 90.37 Billion | -70.59 Billion | 71.56 Billion |
| Other Investing Activities | -43.83 Billion | 36.32 Million | -155.97 Billion | -133.93 Billion | 2.46 Billion | 823.97 Million |
| Financing Cash Flow | -58.24 Billion | -9.4 Billion | -3.06 Billion | -126.78 Billion | -5.6 Billion | -118.69 Billion |
| Debt repayment | -1.02 Billion | -5.59 Billion | -32.26 Billion | -103.37 Billion | -25.8 Billion | -138.39 Billion |
| Dividends payments | -9.22 Billion | - | -127.68 Million | -17.99 Billion | -450.24 Million | -18.57 Billion |
| Common Stock Repurchased | - | -3.28 Billion | - | -3.07 Billion | - | - |
| Common Stock Issuance | - | - | - | 93.51 Million | - | - |
| Other Financing Activities | -48 Billion | - | 29.33 Billion | -2.44 Billion | 20.64 Billion | 38.26 Billion |
| Accounts receivables | -44.76 Billion | 29 Billion | -17.72 Billion | -2.6 Billion | -30.02 Billion | 20.14 Billion |
| Accounts payables | -5.79 Billion | 6.32 Billion | 7.1 Billion | 5.57 Billion | -6.32 Billion | -6.97 Billion |
| Inventory | -6.65 Billion | 14.29 Billion | 14.07 Billion | -16.9 Billion | 4.8 Billion | -11.24 Billion |
| Other working capital | 10.91 Billion | -8.38 Billion | -46.14 Billion | -43.46 Billion | 10.27 Billion | 1.87 Billion |
| Cash at beginning of period | 126.42 Billion | 54.98 Billion | 188.16 Billion | 147.32 Billion | 149.57 Billion | 188.94 Billion |
| Cash at end of period | 47.85 Billion | 126.42 Billion | 54.98 Billion | 54.98 Billion | 188.16 Billion | 149.57 Billion |
| Capital Expenditure | -8.18 Billion | -15.9 Billion | -17.08 Billion | -47.74 Billion | -9.57 Billion | -11.49 Billion |
| Effect of forex changes on cash | 723.6 Million | 1.28 Billion | -1.5 Billion | 1.37 Billion | 2.88 Billion | -6.2 Billion |
| Net cash flow / Change in cash | -78.56 Billion | 71.44 Billion | -133.18 Billion | -92.34 Billion | 38.59 Billion | -39.37 Billion |
| Free Cash Flow | 22.79 Billion | 111.82 Billion | 27.07 Billion | 168.79 Billion | 40.64 Billion | 33.21 Billion |
6741
4991
PDLB
RHC
SSVC
MANAKCOAT